Order Article Reprints

Verma S, Breadner D, Mittal A, Palma DA, Nayak R, Raphael J, Vincent M. An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy. Cancers. 2024; 16(7):1302. https://doi.org/10.3390/cancers16071302

Verma, Saurav, Daniel Breadner, Abhenil Mittal, David A. Palma, Rahul Nayak, Jacques Raphael, and Mark Vincent. 2024. "An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy" Cancers 16, no. 7: 1302. https://doi.org/10.3390/cancers16071302

Verma, S., Breadner, D., Mittal, A., Palma, D. A., Nayak, R., Raphael, J., & Vincent, M. (2024). An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy. Cancers, 16(7), 1302. https://doi.org/10.3390/cancers16071302